These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 6649642)

  • 1. [The L-DOPA-propranolol test for the evaluation of reserves in secretory growth hormone].
    Frisch H; Schober E; Stransky E
    Wien Klin Wochenschr; 1983 Aug; 95(16):566-8. PubMed ID: 6649642
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stimulation of growth hormone secretion by levodopa-propranolol in children and adolescents.
    Pediatrics; 1975 Aug; 56(2):262-6. PubMed ID: 169508
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth hormone response in very short children.
    Palayew K; Crock P; Pianosi P; Coates A; Weitzner G; Schiffrin A
    Clin Invest Med; 1991 Aug; 14(4):331-7. PubMed ID: 1782731
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reevaluation of levodopa-propranolol as a test of growth hormone reserve in children.
    Collu R; Brun G; Milsant F; Leboeuf G; Letarte J; Ducharme JR
    Pediatrics; 1978 Feb; 61(2):242-4. PubMed ID: 634678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Propranolol and exercise as a screening test for growth hormone deficiency.
    Shanis BS; Moshang T
    Pediatrics; 1976 May; 57(5):712-4. PubMed ID: 940711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Growth hormone and IGF1 profile in short children with osteopetrosis.
    al Herbish AS; al Jarallah A; al Jurayyan NA; abo Bakr AM; al Rasheed SA; Mahdi AH
    Clin Invest Med; 1994 Feb; 17(1):26-30. PubMed ID: 8174311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High growth hormone levels in clinically short stature children.
    Awan TM; Sattar A; Khattak IG
    J Ayub Med Coll Abbottabad; 2006; 18(2):29-33. PubMed ID: 16977810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The effects of l-dopa administration on the prolactin levels in short-stature subjects].
    Saggese G; Cesaretti G; Carlotti C; Cioni C; Bracaloni C
    Minerva Pediatr; 1992 Mar; 44(3):73-8. PubMed ID: 1518496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequency of growth hormone deficiency in short statured children.
    Awan TM; Sattar A; Khattak EG
    J Coll Physicians Surg Pak; 2005 May; 15(5):295-8. PubMed ID: 15907242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Response of growth hormone (GH) to glucagon-propranolol stimulation in diabetic subjects (author's transl)].
    Tébar J; Madrid J; Serrano S; Soriano J; Cayuela E; Ascaso J
    Med Clin (Barc); 1981 Apr; 76(8):361-4. PubMed ID: 7253755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth hormone releasing hormone plus arginine stimulation testing in young adults treated in childhood with cranio-spinal radiation therapy.
    Ham JN; Ginsberg JP; Hendell CD; Moshang T
    Clin Endocrinol (Oxf); 2005 May; 62(5):628-32. PubMed ID: 15853837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin-like growth factor-I (IGF-I) screening for the diagnosis of growth hormone (GH) deficiency.
    Sriphrapradang A; Mahachoklertwattana P; Choubtum L; Preeyasombat C
    J Med Assoc Thai; 1997 Jan; 80(1):51-5. PubMed ID: 9078817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic value of growth hormone-releasing hormone tests in short children.
    Kadrnka-Lovrencić M; Verona E
    Acta Med Croatica; 1994; 48(4-5):189-92. PubMed ID: 7534523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Limitations of clinical utility of growth hormone stimulating tests in diagnosing children with short stature.
    Hilczer M; Smyczynska J; Lewinski A
    Endocr Regul; 2006 Sep; 40(3):69-75. PubMed ID: 17100548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of oral administration of ibutamoren mesylate, a nonpeptide growth hormone secretagogue, on the growth hormone-insulin-like growth factor I axis in growth hormone-deficient children.
    Codner E; Cassorla F; Tiulpakov AN; Mericq MV; Avila A; Pescovitz OH; Svensson J; Cerchio K; Krupa D; Gertz BJ; Murphy G
    Clin Pharmacol Ther; 2001 Jul; 70(1):91-8. PubMed ID: 11452249
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Reevaluation of the I-dopa test in acromegaly: anatomo-clinical and prognostic correlations].
    De Marinis L; Mancini A; Zuppi P; Fiumara C; Iacona T; Conte G; Fabrizi ML; Valle D; Anile C; Maira G
    Minerva Chir; 1993 Nov; 48(21-22):1337-40. PubMed ID: 8152567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Twenty-four-hour osteocalcin, carboxyterminal propeptide of type I procollagen, and aminoterminal propeptide of type III procollagen rhythms in normal and growth-retarded children.
    Saggese G; Baroncelli GI; Bertelloni S; Cinquanta L; DiNero G
    Pediatr Res; 1994 Apr; 35(4 Pt 1):409-15. PubMed ID: 8047377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Attempt at potentiation of the action of L-dopa on the secretion of growth hormone by benserazide, disulfiram and propranolol].
    Rochiccioli P; Enjaume P; Dutau G; Ribot C; Augier D
    Arch Fr Pediatr; 1976 Jan; 33(1):55-66. PubMed ID: 985031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Propranolol-insulin stimulation test in the diagnosis of growth hormone deficiency.
    Imura H; Nakai Y; Kato Y; Yoshimoto Y; Moridera K
    Horm Metab Res; 1974 Sep; 6(5):343-6. PubMed ID: 4423606
    [No Abstract]   [Full Text] [Related]  

  • 20. Screening test for growth hormone deficiency: usefulness of L-dopa-propranolol provocative test.
    Lim YJ; Kwan E; Low LC
    J Paediatr Child Health; 1994 Aug; 30(4):328-30. PubMed ID: 7946545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.